Line 122: | Line 122: | ||
<br> | <br> | ||
<img class="myimg" src="https://static.igem.org/mediawiki/2018/a/a1/T--Biomarvel--uhealth.jpg"> | <img class="myimg" src="https://static.igem.org/mediawiki/2018/a/a1/T--Biomarvel--uhealth.jpg"> | ||
+ | <br> | ||
<br> | <br> | ||
<img class="myimg" src="https://static.igem.org/mediawiki/2018/d/d8/T--Biomarvel--mainhome2.jpg"> | <img class="myimg" src="https://static.igem.org/mediawiki/2018/d/d8/T--Biomarvel--mainhome2.jpg"> |
Revision as of 13:02, 30 September 2018
ABSTRACT
The goal of this project is to construct a novel fusion protein of gold binding polypeptides (GBP)-protein G (ProG) to develop an electrochemical biosensor for rapid and simple diagnosis and monitoring heart failure.
DH5-alpha E. coli strain was transformed by a genetically modified recombinant vector coding GBP and ProG. The GBP-ProG fusion protein was derived from the strain with IPTG-induced expression and purified using the TALON metal affinity resin. The resulting GBP-ProG was directly self-immobilized onto gold surfaces via the GBP portion, followed by the oriented binding of antibodies onto the ProG domain targeting the Fc region of antibodies.